Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Binding of Pimecrolimus and Tacrolimus to Skin and Plasma Proteins: Implications for Systemic Exposure after Topical Application

H. Markus Weiss, Marcel Fresneau, Thomas Moenius, Anton Stuetz and Andreas Billich
Drug Metabolism and Disposition September 2008, 36 (9) 1812-1818; DOI: https://doi.org/10.1124/dmd.108.021915
H. Markus Weiss
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcel Fresneau
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Moenius
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anton Stuetz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Billich
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 36 no. 9 1812-1818
DOI 
https://doi.org/10.1124/dmd.108.021915
PubMed 
18524871

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received April 17, 2008
  • Accepted June 3, 2008
  • Published online August 20, 2008.

Article Versions

  • Earlier version (June 4, 2008 - 08:18).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. H. Markus Weiss,
  2. Marcel Fresneau,
  3. Thomas Moenius,
  4. Anton Stuetz and
  5. Andreas Billich
  1. Novartis Pharma AG, Basel, Switzerland (H.M.W., M.F., T.M., A.B.); and Novartis Institutes for BioMedical Research, Vienna, Austria (A.S.)
  1. Address correspondence to:
    Dr. H. Markus Weiss, Novartis Pharma AG, DMPK, WSJ-210.4.25, CH-4002, Basel, Switzerland. E-mail: markus.weiss{at}novartis.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to May 2023

AbstractFullPdf
Aug 201703410
Sep 201714525
Oct 201703712
Nov 201703816
Dec 20170196
Jan 201805414
Feb 20181328
Mar 201802112
Apr 20182314
May 20180354
Jun 20180319
Jul 201813114
Aug 201803537
Sep 201802112
Oct 20180675
Nov 201808014
Dec 201862115
Jan 20198735
Feb 20197097
Mar 20194317
Apr 20194315
May 20192405
Jun 20192119
Jul 20191633
Aug 20193234
Oct 20192649
Nov 20192127
Dec 20192015
Jan 20203339
Feb 20202211
Mar 20204947
May 20201900
Jun 20203211
Jul 20201711
Aug 20202815
Sep 20203534
Oct 20202734
Nov 20202134
Dec 20202011
Jan 20212236
Feb 20212611
Mar 20213344
Apr 20212310
May 20213055
Jun 20212021
Jul 20211815
Aug 20212454
Sep 20211843
Oct 20212747
Nov 20213134
Dec 20213233
Jan 20223111
Feb 20222172
Mar 202226109
Apr 20222753
May 20222421
Jun 20223823
Jul 202244414
Aug 20223933
Sep 20222343
Oct 20223126
Nov 20224315
Dec 20221610
Jan 20233222
Feb 20232122
Mar 20233555
Apr 20232535
May 20233326

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 36 (9)
Drug Metabolism and Disposition
Vol. 36, Issue 9
1 Sep 2008
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Binding of Pimecrolimus and Tacrolimus to Skin and Plasma Proteins: Implications for Systemic Exposure after Topical Application
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Binding of Pimecrolimus and Tacrolimus to Skin and Plasma Proteins: Implications for Systemic Exposure after Topical Application

H. Markus Weiss, Marcel Fresneau, Thomas Moenius, Anton Stuetz and Andreas Billich
Drug Metabolism and Disposition September 1, 2008, 36 (9) 1812-1818; DOI: https://doi.org/10.1124/dmd.108.021915

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Binding of Pimecrolimus and Tacrolimus to Skin and Plasma Proteins: Implications for Systemic Exposure after Topical Application

H. Markus Weiss, Marcel Fresneau, Thomas Moenius, Anton Stuetz and Andreas Billich
Drug Metabolism and Disposition September 1, 2008, 36 (9) 1812-1818; DOI: https://doi.org/10.1124/dmd.108.021915
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Sex- and lifestyle-related factors affect hepatic CYP levels
  • Adipocyte PXR does not play an essential role in obesity.
  • CYP3A-mediated oxidation of DABE and BIBR0951
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics